Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

OBJECTIVE: To estimate the cost-effectiveness of fluticasone propionate–salmeterol combination (FSC) compared to salmeterol for maintenance therapy in severe chronic obstructive pulmonary disease (COPD). STUDY DESIGN: Pooled economic analysis. METHODS: We performed an economic analysis of pooled dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Anand A, St Charles, Meaghan, Petersen, Hans V, Roberts, Melissa H, Blanchette, Christopher M, Manavi-Zieverink, Kathy
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921685/
https://www.ncbi.nlm.nih.gov/pubmed/20714371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921685/
https://www.ncbi.nlm.nih.gov/pubmed/20714371

Ejemplares similares